Recruiting
Phase 1

Radiation Therapy with Vancomycin

Sponsor:

Abramson Cancer Center at Penn Medicine

Code:

NCT07478848

Conditions

Large B Cell Lymphoma

Non Hodgkin Lymphoma (NHL)

Diffuse Large B Cell Lymphoma (DLBCL)

Diffuse Large B Cell Lymphoma Refractory

Diffuse Large B Cell Lymphoma Relapsed

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Vancomycin 125mg

Radiation Therapy

CAR-T

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-07-14. This information was provided to ClinicalTrials.gov by Abramson Cancer Center at Penn Medicine on 2026-07-01.